期刊文献+

N末端脑利钠肽原在川崎病患儿中的变化及其意义 被引量:28

Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice
原文传递
导出
摘要 目的探讨N末端脑利钠肽原(N-terminalpro-brainnatriureticpeptide,NT-proBNP)在川崎病(Kawasakidisease,KD)患儿中的变化及其临床意义。方法分别测定13例确诊为KD患儿急性期的血浆NT-proBNP水平,并测定了其中的8例恢复期患儿血浆NT-proBNP水平,同时以9例小儿上呼吸道感染急性期为对照组的血浆NT-proBNP水平。分别测定KD患儿在急性期及恢复期的外周血白细胞计数(whitebloodcell,WBC)、C反应蛋白(C-reactiveprotein,CRP)及血浆心肌肌钙蛋白(cardiactroponinI,cTnI)水平,常规超声心动图检测左心室舒张末期内径(leftventricularenddiastolicdiameter,LVDd)、射血分数(leftventricularejectionfraction,LVEF)、舒张期二尖瓣血流频谱速度及冠状动脉病变情况。结果KD患儿急性期血浆NT-proBNP水平为(691±86)ng/L,而对照组小儿血浆中NT-proBNP水平为(47±10)ng/L,两组相比差异具有统计学意义(P<0·001)。有8例KD患儿同时测定了急性期及恢复期血浆NT-proBNP水平。急性期患儿血浆NT-proBNP水平为(636±89)ng/L,在恢复期血浆NT-proBNP水平显著降低,为(164±35)ng/L(P<0·01)。通过直线回归分析,KD患儿急性期血浆NT-proBNP水平与左心室EF、LVDd均无相关关系,同时与患儿舒张期二尖瓣血流频谱E峰及A峰比值也无相关关系。但是,KD患儿急性期血浆NT-proBNP水平与患儿急性期CRP、WBC呈显著正相关(r分别为0·615及0·547,均P<0·05),同时还与急性期患儿的心肌肌钙蛋白水平呈显著正相关(r=0·611,P<0·05)。结论血浆NT-proBNP水平在KD急性期显著升高,而在疾病恢复期其水平明显降低。KD患儿急性期血浆NT-proBNP水平的升高可能与急性期KD患儿的心肌炎症及炎性因子的升高有关。 Objective Brain natriuretic peptide (BNP) is a cardiac hormone and its plasma level increases in congestive heart failure and myocarditis. An increased level of serum BNP has been reported in children in the acute stage of Kawasaki disease (KD). But the mechanism of increased level of BNP in children with KD has not been elucidated and the change in BNP in children with KD in China has not been reported. The aim of this study was to investigate the change in plasma N-terminal pro-brain natriuretic peptide ( NT-pro BNP) in children with KD, examine the value of NT-pro BNP in the diagnosis of KD and explore the mechanism of the change in plasma NT-pro BNP in children with KD. Methods Thirteen patients, aged from 4 months to 56 months, with KD were enrolled and nine patients with acute upper respiratory infection were used as controls. Blood sample was obtained to measure plasma NT-pro BNP concentrations in the acute (n = 13) and convalescent (n =8) phases of KD and in the acute phase of the control patients. Plasma NT-pro BNP was measured using enzyme immunoassay. Other laboratory data including complete blood cell count, C-reactive protein, etc, were also measured in acute phase in both groups. The serum cardiac troponin I was also detected in acute phase of children with KD. All patients with KD had complete echocardiographic study, including measurement of left ventricular end diastolic diameter (LVDd), left ventricular ejection fraction (LVEF) and left ventricular inflow velocity through the mitral annulus (including E-velocity and A-velocity). Two dimensional echocardiography was performed to check for coronary lesions of patients with KD. The correlation between plasma NT-pro BNP and the above parameters was analyzed. Results The mean plasma NT-pro BNP concentration in patients with KD in the acute phase was(691±86) ng/L, and it was (47 ± 10) ng/L in patients of control group. The plasma NTpro BNP in patients with KD in the acute phase was significantly higher than that of the control group ( P 〈 0. 001 ). In 8 cases of KD, the plasma NT-pro BNP concentrations were measured both in the acute and convalescent phase. The mean plasma NT-pro BNP concentration in the acute phase of KD was (636 ± 89 ) ng/L and it was ( 164 ± 35 ) ng/L in the convalescent phase. The level of plasma NT-pro BNP decreased significantly in the convalescent phase ( P 〈 0. 01 ). Through linear regression analysis, there was no significant correlation between the plasma concentrations of NT-pro BNP in acute phase of KD and LVEF, LVDd and E/A ratio, respectively. But the NT-pro BNP level correlated positively with C-reactive protein and white blood cells counts ( r =0. 615, P 〈 0. 05 and r = 0. 547, P 〈 0. 05 ), respectively. NT-pro BNP level correlated positively with serum cTnI, a sensitive biologic marker of cardiac injury (r = 0. 611, P 〈 0. 05 ). Conclusion The plasma NT-pro BNP concentration increased in the acute phase and decreased significantly in the convalescent phase of KD. The plasma NT-pro BNP might be one of the useful biological markers of KD, and the mechanism of change in plasma NT-pro BNP in KD might be associated with cardiac injury and inflammatory factors.
出处 《中华儿科杂志》 CAS CSCD 北大核心 2006年第12期886-890,共5页 Chinese Journal of Pediatrics
基金 首都医学发展基金资助项目(2003-1018) 国家重点基础研究发展规划资助项目(2006CB503807)
关键词 黏膜皮肤淋巴结综合征 肽碎片 利钠肽 Mucocutaneous lymph node syndrome Peptide fragments Natriuretie peptide,brain
  • 相关文献

参考文献10

  • 1Witt MT,Minich LL,Bohnsack JF,et al.Kawasaki disease:more patients are being diagnosed who do not meet American Heart Association criteria.Pediatrics,1999,104:e10.
  • 2王琍,林毅,苏英姿,汪芸,赵地,吴铁吉.283例川崎病的临床分析[J].中华儿科杂志,2004,42(8):609-612. 被引量:84
  • 3Kawamura T,Wago M,Kawaguchi H,et al.Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease.Pediatr Int,2000,42:241-248.
  • 4Ayuswa M,Sonobe T,Uemura S,et al.Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition).Pediatr Int,2005,47:232-234.
  • 5Newburger JW,Takahashi M,Gerber MA,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever,Endocarditis and Kawasaki Disease,Council on Cardiovascular Disease in the Young,American Heart Association.Circulation,2004,110:2747-2771.
  • 6吴瑞萍 胡亚荚.实用儿科学(第6版)[M].北京:人民卫生出版社,2002,9..
  • 7Mir TS,Marohn S,Laer S,et al.Plasma concentrations of N-terminal pro-brain natriurtic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure.Pediatrics,2002,110:e76.
  • 8武育蓉,陈树宝,黄美蓉,张玉奇,孙锟,陈笋.氨基末端脑利钠肽前体在室间隔缺损合并心力衰竭诊断中的价值[J].中华儿科杂志,2005,43(3):161-164. 被引量:37
  • 9Kurotobi S,Kawakami N,Shimizu K,et al.Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease.Pediatr Cardiol,2005,26:425-430.
  • 10Takemura G,Fujiwara H,Takatsu Y,et al.Ventricular expression of atrial and brain natriuretic peptides in patients with myocarditis.Int J Cardiol,1995,52:213-222.

二级参考文献22

  • 1姚渭清,陈树宝,周爱卿,王荣发,孙锟,黄美蓉,邓杏飞,高伟.室间隔缺损合并心力衰竭的机理研究[J].中华儿科杂志,1994,32(3):139-141. 被引量:23
  • 2Mir TS, Marohn S, Laer S,et al. Plasma concentrations of N-terminal pro-brain natriurtic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure.Pediatrics,2002,110:e76.
  • 3Kawai K,Hata K,Takaoka H,et al. Plasma brain natriuretic peptide as a noval therapetic indicator in idiopathic dilated cardiomyopathy during β-blocker therapy: a potential of hormone-guided treatment.Am Heart J,2001,141:925-932.
  • 4Grzybowski J,Bilinska ZT,Janas J,et al. Plasma concentrations of N-terminal brain natriuretic peptide are raised in asymptomatic relatives of dilatec cardiomyopathy patients with left ventricular enlargement.Heart,2002,88:191-192.
  • 5Suneel T,Downie P,Davies J,et al. Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis.Eur J Heart Fail,2001,3:15-19.
  • 6Kinnunen P,Vuolteenaho O,Ruskoaho H,et al. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium:effect of stretching.Endocrinology,1993,132:1961-1970.
  • 7Suda K, Matsumura M, Matsumoto M. Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int,2003,45:249-254.
  • 8Colann SD,Borow KM,Neumann A. Left ventricular end-systolic wall stress-velocity of fiber shortening relation:a load-independent index of myocardial contractility.J Am Coll Cardiol,1984,4:715-721.
  • 9Kimball T,Daniels S,Meyer R,et al. Relation of symptoms to contractility and defect size in infants with ventricular septal defect.Am J Cardiol,1991,67:1097-1102.
  • 10Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation, 1993,87:1776-1780.

共引文献119

同被引文献373

引证文献28

二级引证文献103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部